528 related articles for article (PubMed ID: 20962084)
1. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.
Pena L; Vincent AL; Ye J; Ciacci-Zanella JR; Angel M; Lorusso A; Gauger PC; Janke BH; Loving CL; Perez DR
J Virol; 2011 Jan; 85(1):456-69. PubMed ID: 20962084
[TBL] [Abstract][Full Text] [Related]
2. Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu.
Solórzano A; Ye J; Pérez DR
J Virol; 2010 May; 84(9):4587-96. PubMed ID: 20181702
[TBL] [Abstract][Full Text] [Related]
3. A bivalent live attenuated influenza virus vaccine protects against H1N2 and H3N2 viral infection in swine.
Landreth S; Detmer S; Gerdts V; Zhou Y
Vet Microbiol; 2021 Feb; 253():108968. PubMed ID: 33418392
[TBL] [Abstract][Full Text] [Related]
4. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
[TBL] [Abstract][Full Text] [Related]
5. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
[TBL] [Abstract][Full Text] [Related]
6. The temperature-sensitive and attenuation phenotypes conferred by mutations in the influenza virus PB2, PB1, and NP genes are influenced by the species of origin of the PB2 gene in reassortant viruses derived from influenza A/California/07/2009 and A/WSN/33 viruses.
Broadbent AJ; Santos CP; Godbout RA; Subbarao K
J Virol; 2014 Nov; 88(21):12339-47. PubMed ID: 25122786
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines.
Loeffen WL; Stockhofe N; Weesendorp E; van Zoelen-Bos D; Heutink R; Quak S; Goovaerts D; Heldens JG; Maas R; Moormann RJ; Koch G
Vet Microbiol; 2011 Sep; 152(3-4):304-14. PubMed ID: 21664078
[TBL] [Abstract][Full Text] [Related]
8. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.
Wen F; Yu H; Yang FR; Huang M; Yang S; Zhou YJ; Li ZJ; Tong GZ
Arch Virol; 2014 Nov; 159(11):2957-67. PubMed ID: 24957653
[TBL] [Abstract][Full Text] [Related]
10. Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine.
Nogales A; Steel J; Liu WC; Lowen AC; Rodriguez L; Chiem K; Cox A; García-Sastre A; Albrecht RA; Dewhurst S; Martínez-Sobrido L
Microbiol Spectr; 2022 Jun; 10(3):e0007822. PubMed ID: 35583364
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs.
Ruan BY; Wen F; Gong XQ; Liu XM; Wang Q; Yu LX; Wang SY; Zhang P; Yang HM; Shan TL; Zheng H; Zhou YJ; Tong W; Gao F; Tong GZ; Yu H
Vet Microbiol; 2018 Aug; 222():75-84. PubMed ID: 30080677
[TBL] [Abstract][Full Text] [Related]
12. Double-attenuated influenza virus elicits broad protection against challenge viruses with different serotypes in swine.
Mamerow S; Scheffter R; Röhrs S; Stech O; Blohm U; Schwaiger T; Schröder C; Ulrich R; Schinköthe J; Beer M; Mettenleiter TC; Stech J
Vet Microbiol; 2019 Apr; 231():160-168. PubMed ID: 30955804
[TBL] [Abstract][Full Text] [Related]
13. Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011-2012 H3N2v.
Kitikoon P; Gauger PC; Anderson TK; Culhane MR; Swenson S; Loving CL; Perez DR; Vincent AL
Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):32-41. PubMed ID: 24224818
[TBL] [Abstract][Full Text] [Related]
14. Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.
Zhou B; Li Y; Speer SD; Subba A; Lin X; Wentworth DE
Vaccine; 2012 May; 30(24):3691-702. PubMed ID: 22449422
[TBL] [Abstract][Full Text] [Related]
15. An eight-segment swine influenza virus harboring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs.
Masic A; Pyo HM; Babiuk S; Zhou Y
J Virol; 2013 Sep; 87(18):10114-25. PubMed ID: 23843633
[TBL] [Abstract][Full Text] [Related]
16. Development of an Alternative Modified Live Influenza B Virus Vaccine.
Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
[TBL] [Abstract][Full Text] [Related]
17. Immunization of pigs with an attenuated pseudorabies virus recombinant expressing the haemagglutinin of pandemic swine origin H1N1 influenza A virus.
Klingbeil K; Lange E; Teifke JP; Mettenleiter TC; Fuchs W
J Gen Virol; 2014 Apr; 95(Pt 4):948-959. PubMed ID: 24431235
[TBL] [Abstract][Full Text] [Related]
18. Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.
Yang H; Chen Y; Shi J; Guo J; Xin X; Zhang J; Wang D; Shu Y; Qiao C; Chen H
Vet Microbiol; 2011 Sep; 152(3-4):229-34. PubMed ID: 21596495
[TBL] [Abstract][Full Text] [Related]
19. Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.
Loving CL; Lager KM; Vincent AL; Brockmeier SL; Gauger PC; Anderson TK; Kitikoon P; Perez DR; Kehrli ME
J Virol; 2013 Sep; 87(17):9895-903. PubMed ID: 23824815
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.
Abente EJ; Rajao DS; Santos J; Kaplan BS; Nicholson TL; Brockmeier SL; Gauger PC; Perez DR; Vincent AL
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
